(IPRAM)

Current Research Areas:

1. Psychiatric epidemiology and bio-behavioral assessment with focus on post-traumatic stress disorder, substance abuse and suicidality
2. Human-genome epidemiology of substance use and psychiatric disorder comorbidity
3. Health disparity research on substance abuse with focus on Asian populations.

Rumi Kato Price is the Principal of IPRAM. She was appointed is Research Associate Professor in the Department of Psychiatry in 2000. She obtained her Ph.D. from University of California, Berkeley. She is Co-Director of National Institute on Drug Abuse (NIDA) Pre- and Post-Doctoral Training Program in Comorbidity and Biostatistics. She has received an Independent Scientist Award from NIDA and has conducted several NIMH and NIDA studies to date in the areas of psychiatric and substance abuse epidemiology. As the Principal Investigator, major accomplishments to date include: a longitudinal study of a cohort of Vietnam Veterans followed up over 30 years to date (Washington University Vietnam Era Study); a genetic epidemiology study of an Asian population (St. Louis Asian Health Study); a developmental transition study of 5 international sites (Cross-Cultural Epidemiology-I); and applications of computational approaches to the study of suicidality. IPRAM's study aims are expanding to include genetic-behavioral-social (B-G-S) models of post-traumatic stress disorder and substance abuse comorbidity and human-genome epidemiology focusing on race/ethnicity, substance use and abuse. Dr. Price is native Japanese and has been collaborating with researchers from the Japan.